TrialHeart (British Cardiac Society)2017

Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk.

Robert D Brook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.